Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-30.56%
0%
-30.56%
6 Months
40.85%
0%
40.85%
1 Year
7.53%
0%
7.53%
2 Years
47.06%
0%
47.06%
3 Years
-10.71%
0%
-10.71%
4 Years
-20.63%
0%
-20.63%
5 Years
4900.0%
0%
4900.0%
Modern Chinese Medicine Group Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-22.26%
EBIT Growth (5y)
-45.52%
EBIT to Interest (avg)
97.34
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.48
Sales to Capital Employed (avg)
0.74
Tax Ratio
34.72%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
52.73%
ROE (avg)
14.49%
Valuation key factors
Factor
Value
P/E Ratio
40
Industry P/E
Price to Book Value
0.81
EV to EBIT
6.70
EV to EBITDA
4.82
EV to Capital Employed
0.65
EV to Sales
0.75
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
9.64%
ROE (Latest)
2.04%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'20 - YoY
Dec'20
Dec'19
Change(%)
Net Sales
105.10
50.90
106.48%
Operating Profit (PBDIT) excl Other Income
28.30
15.70
80.25%
Interest
0.10
0.00
Exceptional Items
-7.30
-13.10
44.27%
Consolidate Net Profit
12.60
5.90
113.56%
Operating Profit Margin (Excl OI)
264.20%
300.20%
-3.60%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2020 is 106.48% vs -3.96% in Dec 2019
Consolidated Net Profit
YoY Growth in quarter ended Dec 2020 is 113.56% vs -61.94% in Dec 2019
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
232.10
380.20
-38.95%
Operating Profit (PBDIT) excl Other Income
36.00
82.70
-56.47%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
10.50
53.90
-80.52%
Operating Profit Margin (Excl OI)
111.70%
198.70%
-8.70%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -38.95% vs -18.20% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -80.52% vs -47.21% in Dec 2023
About Modern Chinese Medicine Group Co., Ltd. 
Modern Chinese Medicine Group Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






